Gary DeCrescenzo

This inventor holds 21 USPTO granted patents and 8 published patent applications and 9 EPO patents, primarily in Cancer Treatment. Top assignees: Biomed Valley Discoveries, Inc., Vertex Pharmaceuticals, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary DeCrescenzo. Retrieved from https://idiyas.com/inventor/gary-decrescenzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 8)

% Patents Active = 90.5

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

21 out of 42

Biomed Valley Discoveries, Inc.

patents

5 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

2 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 1 out of 97

Albany Molecular Research, Inc.

patents

5. 1 out of 1,217

The United States of America as Represented by the Department of Health

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Non-ERK MAPK Pathway

CDK Inhibitors

BRAF Mutations

PI3K/Akt Pathway

MEK Inhibitors

Anti-CD276 Antibodies

TEM8 Antibodies

Crystalline Forms

Cancer Compositions

Combination Therapies

Tumor Detection

Cancer Treatments

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12599593 - METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS (2026-04-14),

2. 12582635 - COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS (2026-03-24),

3. 12187698 - Crystalline forms of CHClNO (2025-01-07),

4. 12076324 - Cancer treatments using combinations of CDK and ERK inhibitors (2024-09-03),

5. 11679112 - Cancer treatments using combinations of CDK and ERK inhibitors (2023-06-20),

6. 11390600 - Crystalline forms of CHClNO (2022-07-19),

7. 11246859 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2022-02-15),

8. 11135225 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-10-05),

9. 11013743 - Cancer treatments using combinations of CDK and ERK inhibitors (2021-05-25),

10. 11007184 - Cancer treatments using combinations of type 2 MEK and ERK inhibitors (2021-05-18),

11. 11007183 - Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors (2021-05-18),

12. 10881646 - Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers (2021-01-05),

13. 10738027 - Crystalline forms of CHClNO (2020-08-11),

14. 10668055 - Cancer treatment using combinations of ERK and RAF inhibitors (2020-06-02),

15. 10604582 - Anti-CD276 antibodies (B7H3) (2020-03-31),

Title: The Innovative Journey of Gary DeCrescenzo

Introduction:

Gary DeCrescenzo, a talented inventor hailing from Parkville, Missouri, has made significant contributions to the world of innovation with his creative mind and problem-solving skills.

Latest Patents:

Gary DeCrescenzo's latest patents include groundbreaking inventions in the field of renewable energy technology, medical devices, and sustainable materials.

Career Highlights:

Throughout his illustrious career, Gary DeCrescenzo has been recognized for his pioneering work in developing cutting-edge solutions for complex challenges. His innovative spirit has led to the creation of several patented technologies that have positively impacted various industries.

Collaborations:

Gary DeCrescenzo has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Gary DeCrescenzo's passion for innovation and dedication to pushing the boundaries of what is possible have established him as a respected figure in the world of inventors. His relentless pursuit of excellence continues to inspire future generations of innovators.

Profile summary based on public USPTO records.